Oral Findings in a Group of Egyptian Pediatric Patients at Endstage Renal Disease
1 other identifier
observational
150
0 countries
N/A
Brief Summary
In Egypt, the prevalence of end stage renal disease in pediatric population has never been estimated on a national scale. The patients at end stage renal disease encounter oral and dental problems that emphasize regular and careful screening . In Egypt, the prevalence of oral findings is not studied so we conduct this study to study the oral findings among a group of pediatric patients at end stage renal disease either on haemodialysis or after kidney transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2019
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2018
CompletedFirst Posted
Study publicly available on registry
July 18, 2018
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedJuly 31, 2019
July 1, 2019
1 month
June 29, 2018
July 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Caries
Clinical examination will be done and Caries index will be used ,Unit is the tooth to determine if there is caries or not
Five minutes
Secondary Outcomes (3)
Enamel hypoplasia
Ten minutes
Oral candidiasis
Five minutes
Gingival overgrowth
Five minutes
Study Arms (2)
Heamodialysis group
Kidney transplantation group
Interventions
The data will be collected through a questionnaire that will be obtained through an interview between the investigator and the parent or the legal guardian
Eligibility Criteria
All pediatric patients at end stage renal disease attending at the center of Pediatric Nephrology and transplantation, El- Mounira children's hospital (Abu El rish) will be enrolled in the study in a consecutive order according to inclusion criteria.
You may qualify if:
- Pediatric patients \<15 years old with a diagnosis of end stage renal disease "stage 5" receiving dialysis.
- Pediatric Patients \< 15 years old with kidney transplantation in the monthly follow up.
- Recorded data for every patient. (Glomerular Filtration Rate, Creatinine level, urea level and calcium level).
You may not qualify if:
- Patients undergoing renal dialysis for reasons other than chronic kidney disease, such as acute renal failure secondary to accidents, trauma, snake poisoning.
- Patients undergoing peritoneal dialysis.
- Patients not physically able to participate in the examination.
- Chronic kidney disease patients at stage 2, 3 and 4.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dentist
Study Record Dates
First Submitted
June 29, 2018
First Posted
July 18, 2018
Study Start
November 1, 2019
Primary Completion
December 1, 2019
Study Completion
January 1, 2020
Last Updated
July 31, 2019
Record last verified: 2019-07